Bender B S, Bell W E, Taylor S, Small P A
Geriatric Research, Education, and Clinical Center, VA Medical Center, Gainesville, FL 32608-1197.
J Infect Dis. 1994 Nov;170(5):1195-200. doi: 10.1093/infdis/170.5.1195.
Mice transgenic for beta 2-microglobulin deletion (beta 2M-/-) were immunized intranasally with either a recombinant vaccinia virus that expressed both nucleoprotein and interleukin-2 or by infection with H3N2 influenza virus; 3-4 weeks later they were challenged with H1N1 influenza virus. The immunized beta 2M-/- mice had increased survival and enhanced clearance of virus relative to nonimmune controls. This protection correlated with the development of class II major histocompatibility complex-restricted pulmonary cytotoxic T lymphocyte activity and nasal IgA anti-nucleoprotein antibody. Heterotypic immunity can therefore be generated by a mechanism that does not involve class I major histocompatibility complex-restricted T cells.
用β2-微球蛋白缺失转基因小鼠(β2M-/-),经鼻内接种表达核蛋白和白细胞介素-2的重组痘苗病毒,或感染H3N2流感病毒;3-4周后,用H1N1流感病毒对其进行攻击。与未免疫的对照相比,免疫的β2M-/-小鼠存活率提高,病毒清除增强。这种保护作用与II类主要组织相容性复合体限制的肺细胞毒性T淋巴细胞活性及鼻内IgA抗核蛋白抗体的产生相关。因此,异型免疫可通过一种不涉及I类主要组织相容性复合体限制的T细胞的机制产生。